Intuitive Surgical (ISRG) Long-Term Investments (2009 - 2026)
Intuitive Surgical (ISRG) posted Long-Term Investments of $3.4 billion for Q2 2026, down 1.52% on a QoQ basis from $3.5 billion in Q1 2026, and down 18.94% year-over-year from $4.2 billion in Q2 2025.
Analysis
Intuitive Surgical (ISRG) Long-Term Investments (2009 - 2026) Analysis & Trends
Intuitive Surgical has reported Long-Term Investments for 18 years, with the latest figure at $3.4 billion in Q2 2026.
- On a quarterly basis, Long-Term Investments fell 18.94% year-over-year to $3.4 billion in Q2 2026; TTM through Jun 2026 was $3.4 billion, a 18.94% decrease from a year earlier, with the FY2025 full-year figure at $3.1 billion, down 35.69% from the prior year.
- Long-Term Investments was $3.4 billion for Q2 2026 at Intuitive Surgical, down from $3.5 billion in the prior quarter.
- The five-year high for Long-Term Investments was $4.8 billion in Q4 2024, with the low at $1.0 billion in Q3 2023.
- Average Long-Term Investments over 5 years is $3.2 billion, with a median of $3.3 billion recorded in 2025.
- The sharpest annual moves came in 2023 and 2024: Long-Term Investments tumbled 66.05% in 2023, then soared 290.45% in 2024.
- Over 5 years, Long-Term Investments stood at $2.6 billion in 2022, then fell by 19.19% to $2.1 billion in 2023, then soared by 127.32% to $4.8 billion in 2024, then slumped by 35.69% to $3.1 billion in 2025, then rose by 10.01% to $3.4 billion in 2026.
- The last three Long-Term Investments figures came in at $3.4 billion (Q2 2026), $3.5 billion (Q1 2026), and $3.1 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 3.41 Bn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | - |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 2.25 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 244.10 Mn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | - |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.41 Bn |
| Mar 31, 2026 | 3.46 Bn |
| Dec 31, 2025 | 3.10 Bn |
| Sep 30, 2025 | 3.52 Bn |
| Jun 30, 2025 | 4.21 Bn |
| Mar 31, 2025 | 4.59 Bn |
| Dec 31, 2024 | 4.82 Bn |
| Sep 30, 2024 | 4.08 Bn |
| Jun 30, 2024 | 2.93 Bn |
| Mar 31, 2024 | 2.52 Bn |
| Dec 31, 2023 | 2.12 Bn |
| Sep 30, 2023 | 1.04 Bn |
| Jun 30, 2023 | 1.33 Bn |
| Mar 31, 2023 | 1.89 Bn |
| Dec 31, 2022 | 2.62 Bn |
| Sep 30, 2022 | 3.08 Bn |
| Jun 30, 2022 | 3.74 Bn |
| Mar 31, 2022 | 4.42 Bn |
| Dec 31, 2021 | 4.42 Bn |
| Sep 30, 2021 | 4.13 Bn |